ATH alterity therapeutics limited

Ann: Alterity to Deliver Oral Presentation of ATH434 Trial at AAN, page-15

  1. 14,759 Posts.
    lightbulb Created with Sketch. 1589
    This is good planning
    First poster presentation re wearable sensor data
    which will get investors interested because it’s one of our drugs endpoints..( that’s today )

    Then mid week we have Prof Claassen speak on the Topline data …and other data just analysed..

    Don’t panic about the Dow or the Ath SP..
    will happen if the posters attract investors
    maybe not today or tomorrow but within 6 months
    all good
    We wait ..



    https://hotcopper.com.au/data/attachments/6922/6922985-33a8b2e059d35ba752f3bd230be912a7.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.001(6.67%)
Mkt cap ! $147.3M
Open High Low Value Volume
1.5¢ 1.7¢ 1.5¢ $770.2K 49.71M

Buyers (Bids)

No. Vol. Price($)
8 2038332 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 349000 2
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.